Adrenal cortical carcinoma

被引：8
作者：
Boushey R.P. [1 ]
Dackiw A.P.B. [1 ]
机构：
[1] Department of Surgical Oncology, Section of Endocrine Surgery, Princess Margaret Hospital, University of Toronto, 610 University Avenue, Suite 3-130, Toronto, M5G 2M9, ON
来源：
Current Treatment Options in Oncology | 2001年 / 2卷 / 4期
关键词：
Adrenal Tumor; Gossypol; Inferior Vena Cava; Suramin; Varicocele;
D O I：
10.1007/s11864-001-0029-1
中图分类号：
学科分类号：
摘要：
Adrenal cortical carcinoma is a rare endocrine tumor, and complete surgical resection is the only potentially curative treatment. Accurate preoperative biochemical and radiographic evaluation of the patient who presents with an adrenal mass optimizes patient management and facilitates a complete margin-negative resection of the primary tumor—the most important prognostic variable for long-term survival. Response to mitotane or chemotherapy is modest in patients with advanced disease. It is hoped that an improved understanding of the molecular pathogenesis of this challenging tumor will lead to the development of novel treatment strategies. © 2001, Current Science Inc.
引用
收藏
页码：355 / 364
页数：9
相关论文
共 43 条
  • [1] Cancer: Principles and Practice of Oncology Edn 5, (1997)
  • [2] Wooten M.D., King D.K., Adrenal cortical carcinoma. Epidemiology and treatment with mitotane and a review of the literature, Cancer, 72, pp. 3145-3155, (1993)
  • [3] Icard P., Chapuis Y., Andreassian B., Et al., Adrenal cortical carcinoma in surgically treated patients: a retrospective study on 156 cases by the French association of endocrine surgery, Surgery, 112, pp. 972-979, (1992)
  • [4] Lee J.E., Evans D.B., Hickey R.C., Et al., Unknown primary cancer presenting as an adrenal mass: frequency and implications for diagnostic evaluation of adrenal incidentalomas, Surgery, 124, pp. 1115-1122, (1998)
  • [5] Ross N.S., Aron D.C., Hormonal evaluation of the patient with an incidentally discovered adrenal mass, N Engl J Med, 323, pp. 1401-1405, (1990)
  • [6] Doppman J.L., Reinig J.W., Dwyer A.J., Et al., Differentiation of adrenal masses by magnetic resonance imaging, Surgery, 102, pp. 1018-1026, (1987)
  • [7] Schell S.R., Talamini M.A., Udelsman R., Laparoscopic adrenalectomy for nonmalignant disease: improved safety, morbidity, and cost-effectiveness, Surg Endosc, 13, pp. 30-34, (1999)
  • [8] Kopf D., Goretzki P.E., Lehnert H., Clinical management of malignant adrenal tumors, J Cancer Res Clin Oncol, 127, pp. 143-155, (2001)
  • [9] Haak H.R., Hermans J., van de Velde C.J., Et al., Optimal treatment of adrenal cortical carcinoma with mitotane: results in a consecutive series of 96 patients, Br J Cancer, 69, pp. 947-951, (1994)
  • [10] Luton J.P., Cerdas S., Billaud L., Et al., Clinical features of adrenal cortical carcinoma, prognostic factors, and the effect of mitotane therapy, N Engl J Med, 322, pp. 1195-1201, (1990)
12345